Cancer cells must coordinate a suite of survival tactics to spread through the body, and this training network will teach early-career researchers how to unpick those tactics. The project tackles a critical gap: while metastasis causes most cancer deaths, the mechanisms that allow tumour cells to leave their original site, survive in the bloodstream, lie dormant, and then grow in new organs remain poorly understood. By training a cohort of scientists across four work packages—cell fate, tumour environment, latency, and expansion—the network aims to build a workforce capable of translating fundamental biological insights into new drug targets. If successful, the programme could accelerate the development of therapies that block or delay metastasis, directly improving survival for patients whose cancers have spread. This is primarily a training and fundamental science initiative; it does not promise a near-term clinical tool, but past investments in understanding cell migration and dormancy have already led to drugs that prevent bone metastases in breast cancer. Deeper knowledge of these adaptive processes could eventually reshape how oncologists treat advanced disease.
View original technical description
Adaptmet aims to develop an advanced training program encompassing the multifaceted aspects of metastasis adaptation mechanisms, intending to equip budding researchers with the necessary skills to emerge as leaders in this field. A robust mentoring and training strategy, coupled with cutting-edge methodologies and a diverse range of complementary soft skills, are crucial to this endeavour. These skills are imparted through local and network-wide events, fostering seamless research progression and nurturing successful career trajectories. Scientifically, Adaptmet addresses an unmet medical need by harnessing basic science to revolutionize drug development and, ultimately, enhance patient care. Specifically, scientific work packages (WPs) have been designed to approach metastasis from various functional perspectives. In order to metastasize, cancer cells must adeptly coordinate diverse cellular functions (Cell Fate - WP1). Additionally, understanding the intricate interactions between metastatic cells, the host immune system, and tissue stroma is pivotal (Environment - WP2). Crucial aspects such as the kinetics of metastasis and the mechanisms governing latency, particularly, remain inadequately understood (Latency - WP3). Clarifying this complexity, unravelling mechanisms underlying therapy failure, and identifying expansion pathways are central to defining novel therapeutic targets (Expansion - WP4). In essence, Adaptmet stands at the intersection of a rapidly evolving multidisciplinary domain, amalgamating distinct fields that often face challenges in mutual communication. The success of Adaptmet hinges upon robust partnerships, open exchange of ideas, state-ofthe-art methodologies and equipment, and the exploitation of synergistic opportunities among network members. This collaboration spans diverse perspectives, bridging gaps between different disciplines, thereby breaking down barriers and fostering interdisciplinary cohesion.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know